YUK KI CHOI: Open Payments
NPI 1679928535 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 41 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $432 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $150 |
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| Paratek Pharmaceuticals, Inc. | 5 | $93 |
| Gilead Sciences, Inc. | 3 | $93 |
| Ascensia Diabetes Care Us Inc. | 1 | $75 |
| Novo Nordisk Inc | 3 | $64 |
| Radius Health, Inc. | 2 | $43 |
| Dexcom, Inc. | 2 | $41 |
| Phadia US Inc. | 1 | $17 |
Products named: Kerendia, AIRSUPRA, OTEZLA, NUZYRA, EVENITY, Ozempic, Tymlos, Dexcom G6 Transmitter.
Industry payments across NV — which companies pay providers there.
